Testable hypothesis

Premise – Age‑related decline in mitochondrial NAD+ compartmentalization, excessive ANT‑mediated proton leak, and persistent HOTAIR‑driven epigenetic suppression jointly impair electron transport chain (ETC) supercomplex formation and coupling efficiency, limiting ATP output despite intact biogenesis signaling.

Mechanistic insight – The AMPK/SIRT1/PGC-1α axis drives mitochondrial biogenesis, but its translational impact is blunted when NAD+ is unevenly distributed and when proton conductance is mis‑regulated. We propose that three coordinated interventions will rescue coupling:

1. Selective boost of mitochondrial NAD+ import via overexpression or pharmacological activation of the SLC25A45 transporter, raising the matrix NMN/NAD+ ratio without altering cytosolic pools.
2. Mild activation of UCP2 (not UCP3) to fine‑tune proton leak to the range that reduces ROS while preserving ΔΨm, as shown to be protective in basal conditions.
3. Suppression of HOTAIR lncRNA using antisense oligonucleotides or CRISPRi to relieve its inhibitory effect on PGC-1α transcription and on nuclear‑mitochondrial communication.

Together, these steps should increase matrix NAD+ for SIRT1 activation, promote deacetylation of PGC-1α and downstream NRF1/NRF2/TFAM signaling, modestly uncouple respiration to limit oxidative damage, and remove an epigenetic brake on biogenesis genes. The resulting environment favors proper assembly of ETC complexes I, III, and IV into supercomplexes, which enhances electron channeling, reduces slip, and improves the ATP/O ratio.

Predictions (falsifiable)

• In aged murine skeletal muscle (24‑month-old mice):
  • SLC25A45 overexpression alone will increase matrix NAD+ (measured by mito‑SoNar) but will not change ATP/O ratio or supercomplex levels.
  • UCP2 activation alone (via genipin‑derived agonist) will modestly decrease ROS (MitoSOX) and slightly increase leak (Seahorse) without affecting ATP production.
  • HOTAIR knockdown alone will raise PGC-1α mRNA and citrate synthase activity but will not rescue coupling.
  • The triple combination will produce a statistically significant increase in:
    • Matrix NAD+/NADH ratio (3)
    • Supercomplex abundance (BN‑PAGE for I+III+IV assemblies)
    • ATP/O ratio (high‑resolution respirometry with ADP‑phosphorylation readout)
    • Decreased H2O2 emission per unit O2 consumed
    • Improved grip strength and treadmill endurance vs. each monotherapy and aged controls.
• In vitro using C2C12 myotubes subjected to replicative senescence (passage 15):
  • CRISPRi‑mediated HOTAIR silencing will increase nuclear SIRT1 activity (acetyl‑p53 assay) only when mitochondrial NAD+ is elevated by SLC25A45 overexpression.
  • Seahorse mito stress test will show that the combination yields a spare respiratory capacity >30 % higher than senescence controls, while proton leak remains within the 15‑25 % range of basal respiration (optimal protective window).

Falsifiability

If the triple intervention fails to improve ATP/O ratio or supercomplex formation despite verified increases in matrix NAD+, modest UCP2‑mediated leak, and HOTAIR reduction, the hypothesis is falsified. Likewise, if any single manipulation alone recouples respiration to the same extent as the combination, the proposed synergy is unsupported.

Novel mechanistic integration

This hypothesis extends the AMPK/SIRT1/PGC-1α framework by explicitly linking NAD+ compartmental transport, regulated proton conductance via UCP2, and lncRNA‑mediated epigenetic control to the physical assembly of ETC supercomplexes—a layer not addressed in the cited works. It posits that therapeutic efficacy requires simultaneous correction of substrate availability (matrix NAD+), energy dissipation (tight proton leak), and transcriptional repression (HOTAIR), thereby converting biogenesis signals into functional ATP production.